Xilio Therapeutics
XLO
#9617
Rank
โ‚ฌ35.69 M
Marketcap
0,69ย โ‚ฌ
Share price
-5.23%
Change (1 day)
-29.03%
Change (1 year)

EPS for Xilio Therapeutics (XLO)

EPS in 2023 (TTM): -2,90ย โ‚ฌ

According to Xilio Therapeutics's latest financial reports the company's current EPS (TTM) is -2,70ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -2,83ย โ‚ฌ a decrease over its 2021 EPS that were of -2,71ย โ‚ฌ.

EPS history for Xilio Therapeutics from 2021 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-2,90ย โ‚ฌ2.65%
2022-2,83ย โ‚ฌ4.42%
2021-2,71ย โ‚ฌ